Skip to main content

Table 4 Baseline phenotypic classification according to severity and distribution according to developmental assessment and treatment group

From: A review of the clinical outcomes in idursulfase-treated and untreated Filipino patients with mucopolysaccharidosis type II: data from the local lysosomal storage disease registry

 

Classification (n = 40)

(%)

Developmental assessment

Treated (n = 8)

(%)

Untreated (n = 32)

(%)

Total

(n = 40)

(%)

Early progressive

32

(80%)

GDD

2

(25%)

6 (18.75%)

8

(20%)

ID, moderate

0

2

(6.25%)

2

(5%)

ID, severe

0

8

(25%)

8

(20%)

ID, unclassified

2

(25%)

12 (37.5%)

14

(35%)

Slowly progressive

8

(20%)

ID, mild

3

(37.5%)

4

(12.5%)

7

(17.5%)

No cognitive impairment

1

(12.5%)

0

1

(2.5)